{"id":101827,"date":"2020-02-03T09:28:33","date_gmt":"2020-02-03T17:28:33","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2020\/02\/ai-formulated-medicine-to-be-tested-on-humans-for-the-first-time"},"modified":"2020-02-03T09:28:33","modified_gmt":"2020-02-03T17:28:33","slug":"ai-formulated-medicine-to-be-tested-on-humans-for-the-first-time","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2020\/02\/ai-formulated-medicine-to-be-tested-on-humans-for-the-first-time","title":{"rendered":"AI-formulated medicine to be tested on humans for the first time"},"content":{"rendered":"

<\/a><\/p>\n

The drug, known as DSP-1181, was created by using algorithms to sift through potential compounds, checking them against a huge database of parameters, including a patient\u2019s genetic factors. Speaking to the BBC<\/a><\/em>, Exscientia chief executive Professor Andrew Hopkins described the trials as a \u201ckey milestone in drug discovery\u201d and noted that there are \u201cbillions\u201d of decisions needed to find the right molecules for a drug, making their eventual creation a \u201chuge decision.\u201d With AI, however, \u201cthe beauty of the algorithm is that they are agnostic, so can be applied to any disease.\u201d<\/p>\n

We\u2019ve already seen multiple examples of AI being used to diagnose<\/a> illness and analyze<\/a> patient data, so using it to engineer drug treatment is an obvious progression of its place in medicine. But the AI-created drugs do pose some pertinent questions. Will patients be comfortable taking medication designed by a machine? How will these drugs differ from those developed by humans alone? Who will make the rules for the use of AI in drug research? Hopkins and his team hope that these and myriad other questions will be explored in the trials, which will begin in March.<\/p>\n","protected":false},"excerpt":{"rendered":"

The drug, known as DSP-1181, was created by using algorithms to sift through potential compounds, checking them against a huge database of parameters, including a patient\u2019s genetic factors. Speaking to the BBC, Exscientia chief executive Professor Andrew Hopkins described the trials as a \u201ckey milestone in drug discovery\u201d and noted that there are \u201cbillions\u201d of [\u2026]<\/p>\n","protected":false},"author":396,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,412,41,6],"tags":[],"class_list":["post-101827","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-genetics","category-information-science","category-robotics-ai"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/101827","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/396"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=101827"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/101827\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=101827"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=101827"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=101827"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}